NBGI and Ethemba back Birgi Mefar

Ethemba was attracted by the company's market position, its highly specialised production and its prospects for further growth. According to NBGI the healthcare market in Turkey has seen significant growth in recent years driven by economic growth and healthcare reform. The group's chief executive Ustun Baharoglu also participated in the buyout.

The company is looking to expand into new areas of commercial activity in Turkey and internationally.

The vendors are private owners Mustafa Sevket Birgi, Mehmet Birgi, Ayse Emine Brigi and Maya Holding.

Debt
No details regarding the debt structure were disclosed.

Company
Birgi Mefar Group is a pharmaceutical contract manufacturer based in Istanbul. Founded in 1963, the firm provides its services to major domestic and international pharmaceutical companies and focuses on the injectable products segment.

People
Yannis Voyatzis and Mete Ikiz from NBGI, as well as Adam Teeger from Ethemba, managed the transaction.

Advisers
Equity – CMS Cameron McKenna (Legal), Pekin & Bayar Law Firm (Legal), PricewaterhouseCoopers (Financial due diligence), Baker & McKenzie (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• CEE
• Buyouts
• Healthcare
• CMS Cameron McKenna
• PricewaterhouseCoopers